Please check the following:
- {{x.value}}
FREE membership
FREE membership
Join Intelligent Investor today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Congratulations!
You now have free access to InvestSMART, we look forward to helping you on your financial journey.
You now have access to Free Eureka Report Insights, We look forward to helping you on your financial journey.
You now have access to Intelligent Investor Free Insights. We look forward to helping you build a market beating stock portfolio.
Looking for more…
Intelligent Investor Membership
15-day Free Trial
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
No thanks
Looking for more…
Eureka Report Membership
15-day Free Trial
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
No thanks
Gilead Sciences (NASDAQ: GILD) - Share Price and Research
Current share price for GILD : $65.270 1.81 (2.70%)
Currency: USD ($)
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
GILD General Information +
| NASDAQ Code | GILD |
| Industry/Sector | Drug Manufacturers - General |
| Market Cap ($M) | 81,266 |
| GILD Share Price | $65.270 |
| Day High | $67.890 |
| Day Low | $65.090 |
| Last Close | $67.080 |
| GILD Share Price Movement | $1.81 ( 2.70% ) |
Prices as at 4:00, 26 Apr 2024
+Security prices are at best end-of-day and are indicative only.
Related Research
Gilead Sciences (GILD) Upcoming Dividends & Yields
| Currency | Dividend | Frequency of dividend payment | Declare Date | Record Date | Payment Date |
|---|---|---|---|---|---|
| USD | 4.5¢ | Quarterly | 6 Feb 2024 | 15 Mar 2024 | 28 Mar 2024 |
See all dividends from Gilead Sciences (GILD) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
GILD Financial Summary
| Operating Revenue Per Share | Price to Operating revenue | Price to free cash flow | Earnings Yield | PE Ratio | Dividend Yield | Forward Dividend Yield | Forward Earnings Yield |
|---|---|---|---|---|---|---|---|
| $21.97 | $2.97 | $11.06 | 6.71% | 14.91 | 4.5 | 4.59 | 6.34 |
GILD Calendar of Events
| Created Date | Changed Date | Event |
|---|---|---|
| 15 March 2024 | 19 March 2024 | Company Meeting |
FAQs about
What is the current share price of Gilead Sciences (GILD)?
Gilead Sciences's (GILD) current share price is $65.27. This constitutes a price movement of 2.49% when compared to the share price 7 days ago and is -25.23% below GILD's 12-month high of $87.29 per share. Prices are delayed by at least 20 minutes.
What is the share price movement for Gilead Sciences (GILD)?
Relative to the previous close share price of $67.08, Gilead Sciences's (GILD) current share price of $65.27 constitutes a movement of ($1.81) or -2.70%. Gilead Sciences's (GILD) share price movement is -2.49% when compared to 7 days ago and is -25.23% below GILD's 52-week high of $87.29.
What is the 52-week high share price for Gilead Sciences (GILD)?
Gilead Sciences's (GILD) 52-week high is $87.29 which was reached on 20 Jan 2024. Relative to this, GILD's current share price of $65.27 constitutes a ($22.02) or -25.23% drop since that high of $87.29 per GILD share.
What is the 52-week low share price for Gilead Sciences (GILD)?
Gilead Sciences's (GILD) 52-week low is $66.16 which was reached on 19 Apr 2024. Relative to this, GILD's current share price of $65.27 constitutes a ($0.89) or -1.35% drop since that low of $66.16 per GILD share.
What is the daily average trading volume for Gilead Sciences (GILD)?
Over the last 12 months, Gilead Sciences (GILD) has a daily average trading volume of 1,542,317 GILD shares per day.
What was Gilead Sciences (GILD) last dividend payment?
Gilead Sciences (GILD) last dividend payment was $0.77 per share and was paid on 28 Mar 2024. This last GILD dividend included 0% franking.
When does Gilead Sciences (GILD) release its next Annual Report?
Gilead Sciences (GILD) will release its next Annual Report on n/a. Gilead Sciences's (GILD) last annual report was released on n/a.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
